[Admin]

A space to discuss commonly reported Retatrutide side effects based on published trial data and member experiences — please keep the two clearly separate (see note at the bottom).

Commonly reported effects in published trials

• Nausea — the most frequently reported adverse event across incretin-based trials, typically most noticeable early in dose escalation
• Appetite suppression — an expected pharmacological effect rather than a side effect in the traditional sense, but worth discussing as part of the overall experience
• Fatigue — reported by some trial participants, particularly during dose titration
• GI effects — diarrhea, vomiting, and constipation are the other commonly reported gastrointestinal effects alongside nausea
• Exercise tolerance — some participants and researchers have noted temporary changes in exercise capacity, especially during periods of reduced caloric intake
• Other commonly reported effects — injection site reactions and, in some individuals, transient heart rate changes have also been noted in trial safety reporting

For reference, Lilly’s TRIUMPH-1 Phase 3 results reported treatment discontinuation rates due to adverse events of 4.1% (4 mg), 6.9% (9 mg), and 11.3% (12 mg), compared with 4.9% for placebo — useful context for how side-effect burden scaled with dose in that trial.

Published data vs. anecdote

The list above reflects what’s been reported in trial safety data. If you’re sharing your own experience below, that’s valuable too — but please frame it as a personal account, not as a general claim about what “always happens” or a recommendation for how someone else should proceed.

If you’re experiencing concerning symptoms, please seek care from a licensed healthcare professional rather than relying on forum advice. This thread is for educational discussion of reported effects, not a substitute for medical evaluation.

[Author]

Posts